KASINGER JAMES R. - Insider Non-Derivative Transactions at CRISPR Therapeutics AG (CRSP) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 12, 2024, KASINGER JAMES R.'s relationship to CRISPR Therapeutics AG (CRSP) is Officer (General Counsel and Secretary) (General Counsel and Secretary), and currently has 61,174 shares of Common Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CRSP insiders.

Data Source: SEC.
KASINGER JAMES R. - Insider Non-Derivative Transactions of CRSP Common Shares
Apr 01Jul 01Oct 01Jan 01010K20K30K40K50K60K
KASINGER JAMES R. - Insider Non-Derivative Transactions at CRSP
Date
Transaction
No. of Shares
Price Per Share
Shares Owned After Transactions
Mar 13, 2024 Sell -- (Common Shares) 1,146 74.44 61,174
Mar 12, 2024 Sell -- (Common Shares) 2,801 78.26 60,070
Mar 12, 2024 M -- (Common Shares) 2,250 0 62,320
Mar 11, 2024 M -- (Common Shares) 5,500 0 62,871
Feb 21, 2024 Sell -- (Common Shares) 1,913 79.67 57,371
Feb 19, 2024 M -- (Common Shares) 3,825 0 59,284
Mar 14, 2023 F -- (Common Shares) 1,283 43.22 53,616
Mar 14, 2023 F -- (Common Shares) 1,022 43.22 54,844
Mar 12, 2023 M -- (Common Shares) 2,250 0 55,866
Mar 11, 2023 M -- (Common Shares) 2,833 0 54,899
Feb 22, 2023 F -- (Common Shares) 1,950 48.26 52,066
Feb 19, 2023 M -- (Common Shares) 3,825 0 54,016
Items per page:
1 – 12 of 12